Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Thompson

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Journal of Medical Internet Research|August 1, 2023
The Complexity of Transferring Remote Monitoring and Virtual Care Technology Between Countries: Lessons From an International WorkshopQuynh Pham, David Wong, Kaylen J Pfisterer, et al.
Internal Medicine Journal|March 5, 2026
Accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemicLeya Nedumannil, Steven Cheema, Simon J Hume, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
Journal of Hepatology|September 24, 2020
A global investment framework for the elimination of hepatitis BJessica Howell, Alisa Pedrana, Sophia E Schroeder, et al.
The International Journal on Drug Policy|September 15, 2023
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitionersTafireyi Marukutira, Rachel Barter, Karen P Moore, et al.
Gut|August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis BJulianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
BMC Cancer|May 31, 2020
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisationGauri Mishra, Anouk Dev, Eldho Paul, et al.
The New England Journal of Medicine|March 4, 2011
Diabetes mellitus, fasting glucose, and risk of cause-specific deathSreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, et al.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Journal of Medical Internet Research|August 1, 2023
The Complexity of Transferring Remote Monitoring and Virtual Care Technology Between Countries: Lessons From an International WorkshopQuynh Pham, David Wong, Kaylen J Pfisterer, et al.
Internal Medicine Journal|March 5, 2026
Accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemicLeya Nedumannil, Steven Cheema, Simon J Hume, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
Journal of Hepatology|September 24, 2020
A global investment framework for the elimination of hepatitis BJessica Howell, Alisa Pedrana, Sophia E Schroeder, et al.
The International Journal on Drug Policy|September 15, 2023
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitionersTafireyi Marukutira, Rachel Barter, Karen P Moore, et al.
Gut|August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis BJulianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
BMC Cancer|May 31, 2020
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisationGauri Mishra, Anouk Dev, Eldho Paul, et al.
The New England Journal of Medicine|March 4, 2011
Diabetes mellitus, fasting glucose, and risk of cause-specific deathSreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, et al.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
Pageof 16